UCB selects ZoBio for Fragment Based Drug Discovery services(07/16/2007) ZoBio BV announced that UCB S.A. has selected ZoBio to provide ligand discovery services in the field of Fragment Based Drug Discovery. The agreement provides for initial ligand screening of UCB discovery targets. ZoBio will immobilize the targets ...
Top
